Insider Trading: Michael W Linn is Buying $ASPS

Michael W Linn – Director at Altisource Portfolio Solutions (ASPS) – has filed for several insider purchases in the company’s stock. According to the filings, he has bought totally 4,500 shares in ASPS since August 1st. His most recent 2,000 shares purchase was on November 1st, at $40.44 per share. Now Michael W Linn has 6,000 in his position.

Altisource Portfolio Solutions S.A. (NASDAQ:ASPS)

Eight hedge funds in our tracking list were bullish about ASPS in the second quarter. Leon Cooperman’s Omega Advisors had 1.97 million shares; John Kleinheinz’s Kleinheinz Capital Partners had 1.06 million shares.

According to Forbes, Michael W Linn “currently serves on the Board of Directors in Altisource Portfolio Solutions SA and as President and Chief Executive Officer of Greensleeves LLC”. He focuses on increasing the use of alternative energy to power buildings. He also serves as the Board of Directors of National Lime & Stone and is a private investor in energy related industries.  Michael W Linn got a Bachelor of Arts in Harvard College in 1970 and MBA from Harvard Business School in 1973.

Per Yahoo! Finance, Altisource Portfolio Solutions is a mortgage investment company which provides services related to real estate and mortgage portfolio management, asset recovery, and customer relationship management primarily in the United States. The company operates in three segments: Mortgage Services, Financial Services, Technology Services. The company serves the financial services, consumer products and services, utilities, government, real estate, and mortgage servicing sectors. The company was incorporated in 1999 and is based in Luxembourg.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!